share_log

Swelling Losses Haven't Held Back Gains for Establishment Labs Holdings (NASDAQ:ESTA) Shareholders Since They're up 124% Over 5 Years

Swelling Losses Haven't Held Back Gains for Establishment Labs Holdings (NASDAQ:ESTA) Shareholders Since They're up 124% Over 5 Years

股东的损失并没有阻止Establishment Labs Holdings(纳斯达克股票代码ESTA)的收益,因为它们在5年内上涨了124%。
Simply Wall St ·  06/05 10:15

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, you can make far more than 100% on a really good stock. For instance, the price of Establishment Labs Holdings Inc. (NASDAQ:ESTA) stock is up an impressive 124% over the last five years. But it's down 4.3% in the last week. However, this might be related to the overall market decline of 0.6% in a week.

任何一支股票最高可以亏掉100%的本金(假设你不使用杠杆),但好的股票则可以赚取100%以上的利润。例如:Establishment Labs Holdings Inc.(NASDAQ:ESTA)股票在过去5年中上涨了惊人的124%。但在过去一周股价下跌了4.3%。然而,这可能与上周整体市场下跌了0.6%有关。

While this past week has detracted from the company's five-year return, let's look at the recent trends of the underlying business and see if the gains have been in alignment.

虽然过去的一周削弱了公司的五年回报,但让我们看看业务的最近趋势,并查看收益是否已对齐。

Establishment Labs Holdings wasn't profitable in the last twelve months, it is unlikely we'll see a strong correlation between its share price and its earnings per share (EPS). Arguably revenue is our next best option. Shareholders of unprofitable companies usually desire strong revenue growth. That's because it's hard to be confident a company will be sustainable if revenue growth is negligible, and it never makes a profit.

Establishment Labs Holdings在过去12个月内没有盈利,因此其股价与每股收益(EPS)之间的关系并不强。 营业收入可能成为我们的下一个最佳选择。通常,亏损公司的股东都希望看到强劲的营收增长,因为如果营收增长微不足道且公司永远不实现盈利,那么对公司的可持续性将缺乏信心。

In the last 5 years Establishment Labs Holdings saw its revenue grow at 19% per year. That's well above most pre-profit companies. So it's not entirely surprising that the share price reflected this performance by increasing at a rate of 18% per year, in that time. This suggests the market has well and truly recognized the progress the business has made. Establishment Labs Holdings seems like a high growth stock - so growth investors might want to add it to their watchlist.

在过去的5年中,Establishment Labs Holdings的营业收入每年增长了19%,远高于大多数盈利前公司。因此,股价每年增长了18%。这表明市场已经充分认识到该企业所取得的进展。Establishment Labs Holdings似乎是一支高成长股票,成长型投资者可能想将其加入自选股。

The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).

下面的图表显示了收益和营收随时间的变化情况(通过单击图像揭示确切的值)。

earnings-and-revenue-growth
NasdaqCM:ESTA Earnings and Revenue Growth June 5th 2024
纳斯达克(Nasdaq): ESTA于2024年6月5日的盈利和营收增长

We like that insiders have been buying shares in the last twelve months. Even so, future earnings will be far more important to whether current shareholders make money. You can see what analysts are predicting for Establishment Labs Holdings in this interactive graph of future profit estimates.

我们很高兴看到内部人士在过去12个月中购买了股票。即便如此,未来的盈利对当前股东是否能够赚钱更为重要。您可以查看这个交互图表,了解分析师对Establishment Labs Holdings未来利润的预测。

A Different Perspective

不同的观点

Investors in Establishment Labs Holdings had a tough year, with a total loss of 24%, against a market gain of about 24%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Longer term investors wouldn't be so upset, since they would have made 18%, each year, over five years. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For example, we've discovered 2 warning signs for Establishment Labs Holdings that you should be aware of before investing here.

在Establishment Labs Holdings的投资者经历了艰难的一年,总亏损达到了24%,而市场则获得了大约24%的收益。即使是好的股票的股价有时也会下跌,但我们希望在对一个企业的基本指标有所改善之前,可以看到它的股价稳步上涨。长期投资者不会感到太沮丧,因为在过去5年中,他们每年都获得了18%的回报。始终保持可持续的增长势头,当前的抛售可能是一个值得考虑的机会。尽管考虑市场状况可能对股价产生的不同影响是非常值得的,但还有其他更重要的因素。例如,我们发现了2个Establishment Labs Holdings的警告迹象,您在进行投资之前应该意识到这些因素。

Establishment Labs Holdings is not the only stock that insiders are buying. For those who like to find lesser know companies this free list of growing companies with recent insider purchasing, could be just the ticket.

Establishment Labs Holdings并不是唯一一个内部人士在购买股票的公司。对于那些想要寻找不太知名的公司的投资者,这份免费的增长列表提供了最近进行内部购买的公司的信息,可能会是个不错的选择。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

请注意,本文所引述的市场回报反映了目前在美国交易所上市的股票的市场加权平均回报。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有反馈?关于内容有所顾虑?直接和我们联系。或者,发送电子邮件至editorial-team (at) simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发